Achieve Life Sciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $15.8M | $5.3M |
| FY2018 | — | $15.8M | $9.5M |
| FY2019 | — | $18.1M | $16.7M |
| FY2020 | — | $37.3M | $35.9M |
| FY2021 | — | $28.0M | $43.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $15.8M | $5.3M |
| FY2018 | — | $15.8M | $9.5M |
| FY2019 | — | $18.1M | $16.7M |
| FY2020 | — | $37.3M | $35.9M |
| FY2021 | — | $28.0M | $43.0M |